Sotalol



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 34.2%
Drug Use For Unknown Indication 20.0%
Atrial Fibrillation 14.6%
Arrhythmia 6.7%
Hypertension 5.0%
Atrial Flutter 4.2%
Prostate Cancer 2.5%
Atrial Tachycardia 1.7%
Nodal Arrhythmia 1.7%
Cardiac Failure 1.3%
Angina Pectoris 0.8%
Blood Cholesterol Increased 0.8%
Bronchitis 0.8%
Epilepsy 0.8%
Hernia 0.8%
Hypokalaemia 0.8%
Hypothyroidism 0.8%
Influenza 0.8%
Overdose 0.8%
Pain 0.8%
Torsade De Pointes 9.5%
Ventricular Fibrillation 7.9%
Ventricular Tachycardia 7.9%
Hypotension 6.3%
Tachycardia 6.3%
Vomiting 6.3%
Bradycardia 4.8%
Fatigue 4.8%
Overdose 4.8%
Palpitations 4.8%
Syncope 4.8%
Ventricular Extrasystoles 4.8%
Weight Decreased 4.8%
Arrhythmia 3.2%
Headache 3.2%
Nausea 3.2%
Presyncope 3.2%
Sinus Bradycardia 3.2%
Throat Irritation 3.2%
Urinary Retention 3.2%
Secondary
Atrial Fibrillation 19.3%
Drug Use For Unknown Indication 18.5%
Product Used For Unknown Indication 13.8%
Hypertension 11.5%
Coronary Artery Disease 5.1%
Cardiac Disorder 4.5%
Cardiac Failure 4.5%
Arrhythmia 4.1%
Supraventricular Tachycardia 2.9%
Anxiety 2.3%
Type 2 Diabetes Mellitus 1.9%
Anaesthesia 1.6%
Heart Rate Irregular 1.4%
Ventricular Tachycardia 1.4%
Angina Pectoris 1.2%
Blood Cholesterol Increased 1.2%
Maternal Therapy To Enhance Foetal Lung Maturity 1.2%
Pain 1.2%
Blood Pressure 1.0%
Cerebrovascular Accident Prophylaxis 1.0%
Completed Suicide 7.8%
Transient Ischaemic Attack 7.8%
Renal Failure Acute 6.7%
Therapeutic Response Decreased 6.7%
Ventricular Tachycardia 6.7%
Bradycardia 5.6%
Hypotension 5.6%
Overdose 5.6%
Atrial Fibrillation 4.4%
Drug Ineffective 4.4%
Fatigue 4.4%
Pain 4.4%
Rectal Haemorrhage 4.4%
Syncope 4.4%
Xanthopsia 4.4%
Melaena 3.3%
Presyncope 3.3%
Renal Failure 3.3%
Supraventricular Tachycardia 3.3%
Ventricular Arrhythmia 3.3%
Concomitant
Product Used For Unknown Indication 32.3%
Atrial Fibrillation 15.1%
Drug Use For Unknown Indication 11.7%
Hypertension 9.0%
Cardiac Disorder 4.4%
Pain 3.1%
Blood Cholesterol Increased 3.0%
Arrhythmia 2.3%
Diabetes Mellitus 2.1%
Cerebrovascular Accident Prophylaxis 2.1%
Prophylaxis 2.1%
Anticoagulant Therapy 1.9%
Rheumatoid Arthritis 1.8%
Multiple Myeloma 1.4%
Chronic Obstructive Pulmonary Disease 1.4%
Depression 1.3%
Hypothyroidism 1.3%
Type 2 Diabetes Mellitus 1.3%
Blood Pressure 1.2%
Gastrooesophageal Reflux Disease 1.2%
Weight Decreased 11.5%
Atrial Fibrillation 8.7%
Vomiting 8.0%
Urinary Tract Infection 7.7%
International Normalised Ratio Increased 5.4%
Renal Failure Acute 5.1%
Cerebrovascular Accident 4.8%
Dizziness 4.2%
Pruritus 4.2%
Somnolence 4.2%
Off Label Use 3.8%
Pollakiuria 3.8%
Product Quality Issue 3.8%
Ventricular Tachycardia 3.8%
Drug Ineffective 3.5%
Gastrointestinal Haemorrhage 3.5%
Myocardial Infarction 3.5%
Nausea 3.5%
Sepsis 3.5%
Pain 3.2%
Interacting
Drug Use For Unknown Indication 36.4%
Hypertension 25.0%
Arrhythmia 13.6%
Acute Myocardial Infarction 4.5%
Atrial Fibrillation 4.5%
Diabetes 4.5%
Blood Pressure 2.3%
Depression 2.3%
Hypercholesterolaemia 2.3%
Influenza 2.3%
Muscle Spasms 2.3%
Fatigue 14.3%
Drug Interaction 9.5%
Torsade De Pointes 9.5%
Traumatic Brain Injury 9.5%
Ventricular Arrhythmia 9.5%
Catheterisation Cardiac 4.8%
Dyspnoea 4.8%
Frustration 4.8%
Gynaecomastia 4.8%
Long Qt Syndrome 4.8%
Off Label Use 4.8%
Osteoarthritis 4.8%
Palpitations 4.8%
Presyncope 4.8%
Syncope 4.8%